Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02617589 |
|---|---|
| Brief Title: | An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) (CheckMate 498) |
| First Submitted : | November 26, 2015 |
| First Submitted that Met QC Criteria : | November 26, 2015 |
| First Posted : | December 1, 2015 (Estimate) |
| Results First Submitted : | November 30, 2020 |
| Results First Submitted that Met QC Criteria : | January 15, 2021 |
| Results First Posted : | February 3, 2021 |
| Certification/Extension First Submitted : | January 16, 2020 |
| Certification/Extension First Submitted that Met QC Criteria : | January 22, 2020 |
| Certification/Extension First Posted : | January 29, 2020 |
| Last Update Submitted that Met QC Criteria : | March 1, 2023 |
| Last Update Posted : | March 28, 2023 |